Literature DB >> 20143316

Presenting exogenous antigen to T cells.

Clifford V Harding1, Lakshmi Ramachandra.   

Abstract

Antigen processing and presentation experiments can be done with a wide variety of antigen-presenting cells (APCs). Most experiments will use one of the "professional" APC types: dendritic cells (DCs), macrophages, and B lymphocytes. Other types of cells may be used for antigen presentation in some circumstances. Each type of professional APC has an important antigen-presentation function, but the different APC types contribute to different aspects of the immune response. Therefore, selection of an APC type for study must include consideration of the stage or aspect of immune response that is to be modeled in the experiment. An important technical distinction for some types of experiments is whether the APCs are adherent or nonadherent, since this dictates the procedures that must be used to wash the cells as the medium is changed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143316     DOI: 10.1002/0471142735.im1602s88

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  6 in total

1.  Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing.

Authors:  Daimon P Simmons; Pamela A Wearsch; David H Canaday; Howard J Meyerson; Yi C Liu; Ying Wang; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

2.  CD11b+ Ly6Chi Ly6G- immature myeloid cells recruited in response to Salmonella enterica serovar Typhimurium infection exhibit protective and immunosuppressive properties.

Authors:  Jason W Tam; Amy L Kullas; Patricio Mena; James B Bliska; Adrianus W M van der Velden
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

Review 3.  Impact of PRRSV on activation and viability of antigen presenting cells.

Authors:  Irene M Rodríguez-Gómez; Jaime Gómez-Laguna; Librado Carrasco
Journal:  World J Virol       Date:  2013-11-12

4.  Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection.

Authors:  Peyman Bizargity; Kaifeng Liu; Liqing Wang; Wayne W Hancock; Gary A Visner
Journal:  Transplantation       Date:  2012-07-27       Impact factor: 4.939

5.  Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice.

Authors:  Roham Parsa; Pernilla Andresen; Alan Gillett; Sohel Mia; Xing-Mei Zhang; Sofia Mayans; Dan Holmberg; Robert A Harris
Journal:  Diabetes       Date:  2012-06-28       Impact factor: 9.461

6.  Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity.

Authors:  Zining Wang; Feifei Xu; Jie Hu; Hongxia Zhang; Lei Cui; Wenhua Lu; Wenzhuo He; Xiaojuan Wang; Mengyun Li; Huanling Zhang; Wenjing Xiong; Chunyuan Xie; Yongxiang Liu; Penghui Zhou; Jinyun Liu; Peng Huang; Xiaofeng Frank Qin; Xiaojun Xia
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.